These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26183515)

  • 1. Assessment of Liver Fibrosis with Diffusion-Weighted Magnetic Resonance Imaging Using Different b-values in Chronic Viral Hepatitis.
    Kocakoc E; Bakan AA; Poyrazoglu OK; Dagli AF; Gul Y; Cicekci M; Bahcecioglu IH
    Med Princ Pract; 2015; 24(6):522-6. PubMed ID: 26183515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging].
    Zhou ML; Yan FH; Xu PJ; Chen CZ; Shen JZ; Li RC; Ji Y; Shi JY
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1757-61. PubMed ID: 19862980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does steatosis affect the performance of diffusion-weighted MRI values for fibrosis evaluation in patients with chronic hepatitis C genotype 4?
    Besheer T; Razek AAKA; El Bendary M; Abd El Maksoud M; Elalfy H; Zalata K; Elkashef W; Zaghloul H; El Gilany AH
    Turk J Gastroenterol; 2017 Jul; 28(4):283-288. PubMed ID: 28594328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of diagnosing and staging liver fibrosis with diffusion weighted imaging.
    Zhu NY; Chen KM; Chai WM; Li WX; Du LJ
    Chin Med Sci J; 2008 Sep; 23(3):183-6. PubMed ID: 18853855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ.
    Do RK; Chandarana H; Felker E; Hajdu CH; Babb JS; Kim D; Taouli B
    AJR Am J Roentgenol; 2010 Sep; 195(3):671-6. PubMed ID: 20729445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted magnetic resonance imaging for the assessment of liver fibrosis in chronic viral hepatitis.
    Charatcharoenwitthaya P; Sukonrut K; Korpraphong P; Pongpaibul A; Saiviroonporn P
    PLoS One; 2021; 16(3):e0248024. PubMed ID: 33662022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus.
    Besheer T; Elalfy H; Abd El-Maksoud M; Abd El-Razek A; Taman S; Zalata K; Elkashef W; Zaghloul H; Elshahawy H; Raafat D; Elemshaty W; Elsayed E; El-Gilany AH; El-Bendary M
    World J Gastroenterol; 2019 Mar; 25(11):1366-1377. PubMed ID: 30918429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.
    Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Saxena R; Aisen AM
    AJR Am J Roentgenol; 2009 Dec; 193(6):1556-60. PubMed ID: 19933647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.
    Taouli B; Tolia AJ; Losada M; Babb JS; Chan ES; Bannan MA; Tobias H
    AJR Am J Roentgenol; 2007 Oct; 189(4):799-806. PubMed ID: 17885048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of diffusion weighted imaging in combination with conventional MRI signs for inflammation activity of chronic hepatitis B].
    Ren HW; Ye HY; An WM; Dong JH; Liu Y
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(19):1484-1490. PubMed ID: 28535640
    [No Abstract]   [Full Text] [Related]  

  • 11. The value of liver and spleen ADC measurements in the diagnosis and follow up of hepatic fibrosis in chronic liver disease.
    Tokgöz Ö; Unal I; Turgut GG; Yildiz S
    Acta Clin Belg; 2014 Dec; 69(6):426-32. PubMed ID: 25103596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade.
    Fujimoto K; Tonan T; Azuma S; Kage M; Nakashima O; Johkoh T; Hayabuchi N; Okuda K; Kawaguchi T; Sata M; Qayyum A
    Radiology; 2011 Mar; 258(3):739-48. PubMed ID: 21248235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative ADC measurement for liver fibrosis diagnosis in chronic hepatitis B using spleen/renal cortex as the reference organs at 3 T.
    Hong Y; Shi Y; Liao W; Klahr NJ; Xia F; Xu C; Li Y; Guo Q
    Clin Radiol; 2014 Jun; 69(6):581-8. PubMed ID: 24581967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A pilot study of hepatic fibrosis with magnetic resonance diffusion-weighted imaging in a rabbit model].
    Hu XF; Liu B; Qian YF; Zhang C; Yu YQ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):500-4. PubMed ID: 18647527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of apparent diffusion coefficient for predicting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
    Zhang L; Rao SX; Xu XF; Wang DS; Jin da Y; Zeng MS
    Diagn Interv Radiol; 2016; 22(4):308-13. PubMed ID: 27283593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
    Lewin M; Poujol-Robert A; Boëlle PY; Wendum D; Lasnier E; Viallon M; Guéchot J; Hoeffel C; Arrivé L; Tubiana JM; Poupon R
    Hepatology; 2007 Sep; 46(3):658-65. PubMed ID: 17663420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted magnetic resonance imaging for diagnosis of liver fibrosis and inflammation in chronic viral hepatitis: the performance of low or high B values and small or large regions of interest.
    Vaziri-Bozorg SM; Ghasemi-Esfe AR; Khalilzadeh O; Mazloumi M; Nassiri-Toosi M; Ghanaati H; Rokni-Yazdi H
    Can Assoc Radiol J; 2012 Nov; 63(4):304-11. PubMed ID: 22261202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of DWI to assess spleen and liver quantitative ADC changes in the detection of liver fibrosis stages in chronic viral hepatitis.
    Cece H; Ercan A; Yıldız S; Karakas E; Karakas O; Boyacı FN; Aydogan T; Karakas EY; Cullu N; Ulas T
    Eur J Radiol; 2013 Aug; 82(8):e307-12. PubMed ID: 23518145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients.
    Girometti R; Furlan A; Bazzocchi M; Soldano F; Isola M; Toniutto P; Bitetto D; Zuiani C
    Radiol Med; 2007 Apr; 112(3):394-408. PubMed ID: 17440695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.